Status:
WITHDRAWN
HYPERTONIC SALINE IN ACUTE VIRAL BRONCHIOLITIS: A RANDOMIZED CLINICAL TRIAL
Lead Sponsor:
Laval University
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
Centre de Recheche du Centre Hospitalier Université Laval
Conditions:
Acute Viral Bronchiolitis.
Eligibility:
All Genders
6-12 years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether nebulized hypertonic saline solution reduces the admission rate 48 hours after initial treatment in the emergency department, when compared to normal ...
Detailed Description
Acute viral bronchiolitis is the principal lower respiratory tract infection in infants worldwide, 10% of canadian infants are affected each year. It is characterized by a first episode of difficulty ...
Eligibility Criteria
Inclusion
- clinical diagnosis of viral bronchiolitis
- Age 6 weeks to 12 months
- Clinical Score IRAS \>3 and \<8
Exclusion
- prematurity \<30 weeks
- younger than 6 weeks of age
- chronic lung disease
- immunosuppression.
- History of wheezing or asthma.
- Clinical Score IRAS \>9
- parents refuse study
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2014
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00729274
Start Date
November 1 2011
End Date
April 1 2014
Last Update
September 7 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Laval University Hospital Center
Québec, Quebec, Canada, G1V 4G2